Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank73
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-17.41M
↑ 43% vs avg
Percentile
P73
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-30.69M
Historical baseline
PeriodValueYoY Change
TTM$-17.41M+34.1%
2024$-26.43M+49.5%
2023$-52.34M+3.4%
2022$-54.17M-143.6%
2021$124.16M+253.2%
2020$-81.04M-34.0%
2019$-60.46M-16.3%
2018$-51.98M+19.8%
2017$-64.81M-189.1%
2016$-22.41M-